EMERYVILLE, Calif. (AP) _ Adamas Pharmaceuticals Inc. (ADMS) on Monday reported a loss of $12.6 million in its first quarter.

The Emeryville, California-based company said it had a loss of 36 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 48 cents per share.

The drugmaker posted revenue of $19.3 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $19.6 million.

In the final minutes of trading on Monday, the company's shares hit $4.95. A year ago, they were trading at $3.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMS at https://www.zacks.com/ap/ADMS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News